InsiderTrades.com logo
Tim Sykes’ Urgent Trade Alert: “Make this move now”
From Timothy Sykes   |   Ad
Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.
Click here to see the surprising reason why

CGON Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $12,662,968.00
Insider Selling (Last 12 Months): $23,000,088.80

CG Oncology Insider Trading History Chart

This chart shows the insider buying and selling history at CG Oncology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CG Oncology Share Price & Price History

Current Price: $35.23
Price Change: ▼ Price Decrease of -1.09 (-3.00%)
As of 10/31/2024 04:15 PM ET

This chart shows the closing price history over time for CGON up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.

CG Oncology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/29/2024Hong Fang SongDirectorSell650,455$35.36$23,000,088.80586,982View SEC Filing Icon  
1/29/2024Corleen M RocheCFOBuy2,000$19.00$38,000.002,000View SEC Filing Icon  
1/29/2024Decheng Capital Global Life ScMajor ShareholderBuy400,000$19.00$7,600,000.00400,000View SEC Filing Icon  
1/29/2024Hong Fang SongDirectorBuy263,157$19.00$4,999,983.00613,928View SEC Filing Icon  
1/29/2024Vijay KasturiInsiderBuy1,315$19.00$24,985.001,315View SEC Filing Icon  
See Full Table
I was wrong. Dead wrong.
From Porter & Company   |   Ad
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Here’s the full story for you.

SEC Filings (Institutional Ownership Changes) for CG Oncology (NASDAQ:CGON)

26.56% of CG Oncology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CGON by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

CG Oncology Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/30/2024Amalgamated Bank1,621$61K0.0%+107.6%0.002%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC17,595$0.66M0.0%N/A0.026%Search for SEC Filing on Google Icon
9/16/2024Point72 Asia Singapore Pte. Ltd.1,209$38K0.0%-75.5%0.002%Search for SEC Filing on Google Icon
8/19/2024Point72 Asset Management L.P.110,410$3.49M0.0%-40.7%0.166%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC733,695$23.16M0.6%-43.7%1.101%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC106,951$3.38M0.0%-0.9%0.160%Search for SEC Filing on Google Icon
8/15/2024Scientech Research LLC8,803$0.28M0.1%-27.8%0.013%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company60,301$1.90M0.0%-5.4%0.090%Search for SEC Filing on Google Icon
8/15/2024Deerfield Management Company L.P. Series C433,540$13.69M0.2%+811.9%0.651%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.1,209$38K0.0%-75.5%0.002%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP75,982$2.40M0.0%N/A0.114%Search for SEC Filing on Google Icon
8/14/2024Yu Fan1,578,344$49.83M65.1%N/A2.368%Search for SEC Filing on Google Icon
8/14/2024Ally Bridge Group NY LLC174,876$5.52M3.3%-45.4%0.262%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC9,513$0.30M0.0%N/A0.014%Search for SEC Filing on Google Icon
8/13/2024Ensign Peak Advisors Inc60,565$1.91M0.0%N/A0.091%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC43,200$1.36M0.0%+204.2%0.065%Search for SEC Filing on Google Icon
8/9/2024Massachusetts Financial Services Co. MA266,787$8.42M0.0%+2.7%0.400%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc93,084$2.94M0.0%N/A0.140%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers34,229$1.08M0.0%+13.0%0.051%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp89,344$2.82M0.0%+38.4%0.134%Search for SEC Filing on Google Icon
5/17/2024RA Capital Management L.P.1,397,433$61.35M0.8%N/A2.097%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System2,341$0.10M0.0%N/A0.004%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC1,521,432$66.76M0.0%N/A2.283%Search for SEC Filing on Google Icon
5/16/2024BVF Inc. IL1,884,191$82.72M2.3%N/A2.827%Search for SEC Filing on Google Icon
5/16/2024Blackstone Inc.25,000$1.10M0.0%N/A0.038%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD992,118$43.56M0.0%N/A1.489%Search for SEC Filing on Google Icon
5/15/2024Avoro Capital Advisors LLC700,000$30.73M0.4%N/A1.050%Search for SEC Filing on Google Icon
5/14/2024StemPoint Capital LP40,723$1.79M0.5%N/A0.061%Search for SEC Filing on Google Icon
5/14/2024Decheng Capital LLC5,458,810$239.64M32.1%N/A8.191%Search for SEC Filing on Google Icon
5/14/2024American International Group Inc.306,226$13.44M0.0%N/A0.460%Search for SEC Filing on Google Icon
5/13/2024Ameritas Investment Partners Inc.2,320$0.10M0.0%N/A0.003%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,225,018$97.68M0.0%N/A3.339%Search for SEC Filing on Google Icon
5/7/2024TimesSquare Capital Management LLC224,073$9.84M0.1%N/A0.336%Search for SEC Filing on Google Icon
5/1/2024Capstone Investment Advisors LLC18,354$0.81M0.0%N/A0.028%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets11,198$0.49M0.0%N/A0.017%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
CG Oncology logo
CG Oncology, Inc., an oncolytic immunotherapy company, focuses on developing and commercializing backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003 for the treatment of high-risk bacillus calmette guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients; CORE-001 to treat cretostimogene in combination with pembrolizumab in high-risk BCG-unresponsive NMIBC patients; and CORE-002 for the treatment of cretostimogene in combination with the checkpoint inhibitor nivolumab in muscle invasive bladder cancer patients. It also develops PIVOT-006, a cretostimogene monotherapy for intermediate-risk NMIBC following transurethral resection of the bladder tumor; and CORE-008 for treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC patients. CG Oncology, Inc. was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. The company was founded in 2010 and is based in Irvine, California.
Read More on CG Oncology

Today's Range

Now: $35.23
Low: $35.12
High: $36.39

50 Day Range

MA: $36.68
Low: $34.48
High: $39.11

52 Week Range

Now: $35.23
Low: $25.77
High: $50.23

Volume

192,677 shs

Average Volume

657,541 shs

Market Capitalization

$2.36 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of CG Oncology?

CG Oncology's top insider investors include:
  1. Hong Fang Song (Director)
  2. Decheng Capital Global Life Sc (Major Shareholder)
  3. Corleen M Roche (CFO)
  4. Vijay Kasturi (Insider)
Learn More about top insider investors at CG Oncology.

Who are the major institutional investors of CG Oncology?

CG Oncology's top institutional shareholders include:
  1. SG Americas Securities LLC — 0.03%
  2. Amalgamated Bank — 0.00%
Learn More about top institutional investors of CG Oncology stock.

Which institutional investors are buying CG Oncology stock?

Within the last quarter, CGON stock was bought by institutional investors including:
  1. SG Americas Securities LLC
  2. Amalgamated Bank
In the last year, these company insiders have bought CG Oncology stock:
  1. Hong Fang Song (Director)
  2. Decheng Capital Global Life Sc (Major Shareholder)
  3. Corleen M Roche (CFO)
  4. Vijay Kasturi (Insider)
Learn More investors buying CG Oncology stock.
Tim Sykes’ Urgent Trade Alert: “Make this move now”
From Timothy Sykes   |   Ad
Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.
Click here to see the surprising reason why